Published in:
01-09-2009 | Original Article
A Central Pancreatectomy for Benign or Low-Grade Malignant Neoplasms
Authors:
Seiko Hirono, Masaji Tani, Manabu Kawai, Shinomi Ina, Ryohei Nishioka, Motoki Miyazawa, Atsushi Shimizu, Kazuhisa Uchiyama, Hiroki Yamaue
Published in:
Journal of Gastrointestinal Surgery
|
Issue 9/2009
Login to get access
Abstract
Inctroduction
A central pancreatectomy is a parenchyma-sparing procedure that is performed to reduce long-term endocrine and exocrine insufficiency.
Method
In this study, we analyzed the perioperative course, the frequency of postoperative onset of diabetes mellitus, and long-term change of body weight in patients undergoing a central pancreatectomy, in comparison to the patients undergoing a distal pancreatectomy for low-grade neoplasms including cystic neoplasms and neuroendocrine tumors.
Results and Discussion
The rate of postoperative complications including grade B/C pancreatic fistula was no different between both groups. Only one patient undergoing a central pancreatectomy (4.7%) developed new onset of mild diabetes, whereas 35% in the distal pancreatectomy group developed new onset or worsening diabetes (p = 0.0129). The body weight in the distal pancreatectomy group was significant lower than that in the central pancreatectomy group at 1 and 2 years after surgery (1 year; P < 0.0001, 2 years; P = 0.0055), and the body weight in the patients undergoing a central pancreatectomy improved to preoperative values within 2 years after surgery.
Conclusion
A central pancreatectomy is a safe procedure for the treatment of low-grade malignant neoplasms in the pancreatic body; the rate of onset of diabetes is minimal, and the body weight improves early in the postoperative course.